Market Herald logo

Subscribe

Be the first with the news that moves the market
  • Assure Holdings (IOM) has announced its expansion into telemedicine by launching professional neurology services for its IONM services
  • The company has already performed its first telehealth case
  • Assure recently made its first two telehealth hires and is actively recruiting to fill additional positions
  • Assure Holdings works with neurosurgeons and orthopedic spine surgeons to provide services that support intraoperative neuromonitoring activities during invasive surgeries
  • Assure Holdings (IOM) opened trading at C$1.80 per share

Assure Holdings (IOM) has announced its expansion into telemedicine by launching professional neurology services for its IONM services.

The company has already performed its first case using the new telehealth services.

The transition will be straightforward as Assure replaces the third-party vendor they are currently using with professional services furnished through its subsidiary.  

John A. Farlinger, Assure’s executive chairman and CEO, commented,

“The company’s expansion into telehealth represents an important milestone in establishing Assure as the standard of care in the intraoperative neuromonitoring (IONM) industry and a leading provider in the United States.

Further, we intend to market this offering to doctors and medical groups that need telehealth neurology services associated with epilepsy, electroencephalogram (EEG) and sleep disorders, among other services,” he said.

Assure recently made its first two hires relating to the company’s telehealth professional neurology services.

The company is actively recruiting to fill additional positions and expects to gradually add more staff over the course of 2021 and beyond.

Assure Holdings is a Colorado-based company that works with neurosurgeons and orthopedic spine surgeons to provide a turnkey suite of services that support intraoperative neuromonitoring activities during invasive surgeries.

Assure Holdings (IOM) opened trading at C$1.80 per share.

More From The Market Herald

" Cardiol Therapeutics (TSX:CRDL) appoints new directors

Cardiol Therapeutics (CRDL) has appointed Teri Loxam and Chris Waddick to its Board of Directors, effective immediately.

" Leveljump Healthcare (TSXV:JUMP) provides Telehospital purchase update

Leveljump Healthcare (JUMP) has provided the following update on its pending acquisition of Telehospital Corp.
Reliq Health Technologies - CEO Dr. Lisa Crossley

" Reliq Health Technologies (TSXV:RHT) commences clinical trials and announces new contracts

Reliq Health Technologies (RHT) announced that its iUGO Care platform will go live in two clinical trials this month involving over 1,000 patients.

" Defence Therapeutics (CSE:DTC) reports that AccuVAC-PTE7 vaccine provides protection from cervical cancer

Defence Therapeutics (DTC) has announced the development of a dual-acting Accum-linked protein vaccine, AccuVAC-PTE7.